Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Closes Stock Offering

NEW YORK, April 30 (GenomeWeb News) - Bruker BioSciences announced at the close of market yesterday that it has closed its public offering of 17.3 million shares.

 

Of the shares, 3.5 million were sold by the company and 13.8 million by four stockholders related to CEO Frank Laukien. The stock was priced at $4.50 per share.

 

The company said last week that it hoped to raise a total of $12.6 million from the offering. The proceeds will be used for "general corporate purposes, potential acquisitions, and possibly for the repayment of debt," the company said yesterday in a statement.

 

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.